Form 4 for IMDX Insight Molecular Diagnostics Inc.
Accepted 2022-08-17 00:00:00 ET · period of report 2022-08-15 · accession 0001493152-22-023389 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-17 | 2022-08-15 | IMDX | Ross Douglas T. | CSO | A - Grant | $0.00 | +150.0K | 170.3K | +738% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, no par value | 2022-08-15 | A | A | 150,000 | $0.00 | 170,317 | D | — | — | (F1) The Restricted Stock Units shall vest on January 1, 2024 based on the achievement of a pre-determined financial objective related to the Issuer's available cash. |